Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiaohui Zhao, Girish Prajapati, Jenny Tse, Aimee M. Near & Princy N. Kumar. (2023) Weight gain after antiretroviral therapy initiation in people living with HIV in the United States: analyses of electronic medical records and prescription claims. Current Medical Research and Opinion 39:7, pages 997-1006.
Read now
Read now
Wing Chow, Prina Donga, Aurélie Côté-Sergent, Carmine Rossi, Patrick Lefebvre, Marie-Hélène Lafeuille, Hélène Hardy & Bruno Emond. (2020) Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide. Patient Preference and Adherence 14, pages 2315-2326.
Read now
Read now
Articles from other publishers (10)
Cristina Rivera-Picón, María Benavente-Cuesta, María Quevedo-Aguado, Juan Sánchez-González & Pedro Rodríguez-Muñoz. (2023) Factors Associated with Adherence to Treatment in Patients with HIV and Diabetes Mellitus. Journal of Personalized Medicine 13:2, pages 269.
Crossref
Crossref
Xingzhi Wang, Luke Schmerold & Toshio Naito. (2022) Real-world medication persistence among HIV-1 patients initiating integrase inhibitor-based antiretroviral therapy in Japan. Journal of Infection and Chemotherapy 28:11, pages 1464-1470.
Crossref
Crossref
Madhu C Choudhary & John W Mellors. (2022) The transformation of HIV therapy: One pill once a day. Antiviral Therapy 27:2, pages 135965352110623.
Crossref
Crossref
Ruojing Bai, Shiyun Lv, Hao Wu & Lili Dai. (2022) Low-level Viremia in Treated HIV-1 Infected Patients: Advances and
Challenges. Current HIV Research 20:2, pages 111-119.
Crossref
Crossref
Hans Jaeger, Edgar T Overton, Gary Richmond, Giuliano Rizzardini, Jaime Federico Andrade-Villanueva, Rosie Mngqibisa, Antonio Ocampo Hermida, Anders Thalme, Elena Belonosova, Faïza Ajana, Paul D Benn, Yuanyuan Wang, Krischan J Hudson, Carlos Martín Español, Susan L Ford, Herta Crauwels, David A Margolis, Christine L Talarico, Kimberly Y Smith, Veerle van Eygen, Rodica Van Solingen-Ristea, Simon Vanveggel & William R Spreen. (2021) Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. The Lancet HIV 8:11, pages e679-e689.
Crossref
Crossref
Ashima Pyngottu, Alexandra U Scherrer, Roger Kouyos, Michael Huber, Hans Hirsch, Matthieu Perreau, Sabine Yerly, Alexandra Calmy, Matthias Cavassini, Marcel Stöckle, Hansjakob Furrer, Pietro Vernazza, Enos Bernasconi, Huldrych F Günthard, K Aebi-Popp, A Anagnostopoulos, M Battegay, E Bernasconi, J Böni, D L Braun, H C Bucher, A Calmy, M Cavassini, A Ciuffi, G Dollenmaier, M Egger, L Elzi, J Fehr, J Fellay, H Furrer, C A Fux, H F Günthard, D Haerry, B Hasse, H H Hirsch, M Hoffmann, I Hösli, M Huber, C R Kahlert, L Kaiser, O Keiser, T Klimkait, R D Kouyos, H Kovari, B Ledergerber, G Martinetti, B Martinez de Tejada, C Marzolini, K J Metzner, N Müller, D Nicca, P Paioni, G Pantaleo, M Perreau, A Rauch, C Rudin, A U Scherrer, P Schmid, R Speck, M Stöckle, P Tarr, A Trkola, P Vernazza, G Wandeler, R Weber & S Yerly. (2021) Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor–Based Antiretroviral Treatment. Clinical Infectious Diseases 73:7, pages e2134-e2141.
Crossref
Crossref
Aditya H Gaur, Mark F Cotton, Carina A Rodriguez, Eric J McGrath, Elizabeth Helström, Afaaf Liberty, Eva Natukunda, Pope Kosalaraksa, Kulkanya Chokephaibulkit, Heather Maxwell, Pamela Wong, Danielle Porter, Sophia Majeed, Mun Sang Yue, Hiba Graham, Hal Martin, Diana M Brainard & Cheryl Pikora. (2021) Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial. The Lancet Child & Adolescent Health 5:9, pages 642-651.
Crossref
Crossref
Grace A. McComsey, Melissa Lingohr-Smith, Rachel Rogers, Jay Lin & Prina Donga. (2021) Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States. Advances in Therapy 38:9, pages 4961-4974.
Crossref
Crossref
Ingrid T. Katz, Nicholas Musinguzi, Kathleen Bell, Anna Cross, Mwebesa B. Bwana, Gideon Amanyire, Stephen Asiimwe, Catherine Orrell, David R. Bangsberg & Jessica E. Haberer. (2021) Brief Report: The Impact of Disease Stage on Early Gaps in ART in the “Treatment for All” Era—A Multisite Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 86:5, pages 562-567.
Crossref
Crossref
Joshua Cohen, Anne Beaubrun, Richa Bashyal, Ahong Huang, Jieni Li & Onur Baser. (2020) Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries. AIDS Research and Therapy 17:1.
Crossref
Crossref